ELORIUM
Live / Allowed — Fifth extension granted (statement of use) (as of 04 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 11 Apr 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97357965
- Mark type
- Word mark
- Filed
- 11 Apr 2022
- Published for opposition
- 29 Aug 2023
- Attorney of record
- Jayme M. Torelli
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of motion sickness; Pharmaceutical preparations for the treatment and prevention of cravings for opioid substances or opiate substances; Pharmaceutical preparations for the treatment and prevention of nausea; Pharmaceutical preparations for the treatment and prevention of vomiting; Pharmaceutical preparations for the treatment and prevention of substance dependence; Pharmaceutical preparations for the treatment and prevention of anxiety; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by an over-expression of substance P; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by overstimulation of the neurokinin-1 (NK-1) receptor; Pharmaceutical preparations for the treatment of gastroparesis; Pharmaceutical preparations for the treatment of pruritus; Pharmaceutical preparations for the treatment of atopic dermatitis; Pharmaceutical preparations for the treatment of pain; Pharmaceutical preparations for the treatment of a behavioral stressor; Pharmaceutical preparations for treating epidermal problems; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases
Owner
- Vanda Pharmaceuticals Inc., Washington, DC, US
- Vanda Pharmaceuticals Inc., Washington, DC, US
Prosecution history
- 05 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Aug 2026 — SOU EXTENSION 5 GRANTED
- 31 Mar 2026 — SOU EXTENSION 5 FILED
- 03 Aug 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 31 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 20 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Sept 2025 — SOU EXTENSION 4 GRANTED
- 19 Sept 2025 — SOU EXTENSION 4 FILED
- 19 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Mar 2025 — SOU EXTENSION 3 GRANTED
- 12 Mar 2025 — SOU EXTENSION 3 FILED
- 12 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Oct 2024 — SOU EXTENSION 2 GRANTED